Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
A simple, xeno-free method for oligodendrocyte generation from human neural stem cells derived from umbilical cord: engagement of gelatinases in cell commitment and differentiation.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
The burden of multiple sclerosis variants in continental Italians and Sardinians.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Natural killer cells in human autoimmune disorders.
Objective and subjective measures reflect different aspects of balance in multiple sclerosis.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Goal attainment in cognitive rehabilitation in MS patients.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
CX3CR1 in multiple sclerosis.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
The clinical overlap of multiple sclerosis and headache.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.

Pages